Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters

Brain, Behavior, and Immunity

Volumn 70, Issue , 2018, Pages 61-75

  Del Giudice, Marco ^a   Gangestad, Steven W ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

CRP; Cytokines; Depression; IL 6; Inflammation; Life history theory; Socioeconomic status; Somatic maintenance; Stress; Tolerance

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

ACUTE STRESS; ADIPOSE TISSUE; ARTICLE; CHRONIC INFLAMMATION; CHRONIC STRESS; CONCEPTUAL FRAMEWORK; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DISEASE MARKER; HARM REDUCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTIOUS AGENT; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SOCIAL STATUS; TISSUE REPAIR; ANIMAL; IMMUNOLOGY; INFLAMMATION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SOCIAL CLASS;

ANIMALS; BIOMARKERS; C-REACTIVE PROTEIN; DEPRESSION; HUMANS; INFLAMMATION; INTERLEUKIN-6; SIGNAL TRANSDUCTION; SOCIAL CLASS; STRESS, PSYCHOLOGICAL;

EID: 85042678978     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2018.02.013     Document Type: Article

References (162)

1. Adamo, S.A., The effects of stress hormones on immune function may be vital for the adaptive reconfiguration of the immune system during fight-or-flight behavior. Integr. Comp. Biol. 54 (2014), 419–426.
2. Akira, S.H.I.Z.U.O., Hirano, T., Taga, T., Kishimoto, T., Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4 (1990), 2860–2867.
3. Allin, K.H., Nordestgaard, B.G., Zacho, J., Tybjærg-Hansen, A., Bojesen, S.E., C-reactive protein and the risk of cancer: a Mendelian randomization study. J. Natl Cancer Inst. 102 (2010), 202–206.
4. Andrews, P.W., Bharwani, A., Lee, K.R., Fox, M., Thomson, J.A., Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci. Biobehav. Rev. 51 (2015), 164–188.
5. Andrews, P.W., Durisko, Z., The Evolution of Depressive Phenotypes. DeRubeis, R.J., Strunk, D.R., (eds.) The Oxford Handbook of Mood Disorders, 2017, Oxford University Press, New York, NY, 24–36.
6. Ashley, N.T., Weil, Z.M., Nelson, R.J., Inflammation: mechanisms, costs, and natural variation. Annu. Rev. Ecol. Evol. Syst. 43 (2012), 385–406.
7. Ayres, J.S., Schneider, D.S., Tolerance of infections. Annu. Rev. Immunol. 30 (2012), 271–294.
8. Bai, Y., Sun, Q., Macrophage recruitment in obese adipose tissue. Obes. rev. 16 (2015), 127–136.
9. Baumann, H., Morella, K.K., White, D.W., Dembski, M., Bailon, P.S., Kim, H., Tartaglia, L.A., The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Nat. Acad. Sci. U.S.A. 93 (1996), 8374–8378.
10. Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C.M., Mondelli, V., Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol. Psychiatry 21 (2016), 642–649.
11. Berk, M., Williams, L.J., Jacka, F.N., O'Neil, A., Pasco, J.A., Moylan, S., Maes, M., So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med., 11, 2013, 200.
12. Black, S., Kushner, I., Samols, D., C-reactive protein. J. Biol. Chem. 279 (2004), 48487–48490.
13. Blackwell, A.D., Trumble, B.C., Maldonado Suarez, I., Stieglitz, J., Beheim, B., Snodgrass, J.J., Gurven, M., Immune function in Amazonian horticulturalists. Ann. Hum. Biol. 43 (2016), 382–396.
14. Blevins, C.L., Sagui, S.J., Bennett, J.M., Inflammation and positive affect: examining the stress-buffering hypothesis with data from the National Longitudinal Study of Adolescent to Adult Health. Brain Behav. Immun. 61 (2017), 21–26.
15. Bosma-den Boer, M.M., van Wetten, M.L., Pruimboom, L., Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering. Nutr. Metab., 9, 2012, 32.
16. Brooks, G.D., McLeod, L., Alhayyani, S., Miller, A., Russell, P.A., Ferlin, W., Jenkins, B.J., IL6 Trans-signaling promotes KRAS-driven lung carcinogenesis. Cancer Res. 76 (2016), 866–876.
17. Brunner, E.J., Kivimäki, M., Witte, D.R., Lawlor, D.A., Smith, G.D., Cooper, J.A., Shah, T., Inflammation, insulin resistance, and diabetes—Mendelian randomization using CRP haplotypes points upstream. PLoS Med., 5, 2008, e155.
18. Burton, M.D., Sparkman, N.L., Johnson, R.W., Inhibition of interleukin-6 trans-signaling in the bran facilitates recovery from lipopolysaccharide-induced sickness behavior. J. Neuroinf., 8, 2011, 54.
19. Cain, D.W., Cidlowski, J.A., Immune regulation by glucocorticoids. Nat. Rev. Immunol. 17:4 (2017), 233–247.
20. Calcagni, E., Elenkov, I., Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N. Y. Acad. Sci. 1069:1 (2006), 62–76.
21. Campbell, I.L., Erta, M., Lim, S.L., Frausto, R., May, U., Rose-John, S., Hidalgo, J., Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J. Neurosci. 34:7 (2014), 2503–2513.
22. Capuron, L., Lasselin, J., Castanon, N., Role of adiposity-driven inflammation in depressive morbidity. Neuropsychopharmacology 42 (2017), 115–128.
23. Carpenter, L.L., Gawuga, C.E., Tyrka, A.R., Lee, J.K., Anderson, G.M., Price, L.H., Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 35 (2010), 2617–2623.
24. Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., Scheller, J., The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur. J. Cell Biol. 90 (2011), 484–494.
25. Cohen, S., Janicki-Deverts, D., Doyle, W.J., Miller, G.E., Frank, E., Rabin, B.S., Turner, R.B., Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc. Natl. Acad. Sci. USA 109 (2012), 5995–5999.
26. Cua, D.J., Tato, C.M., Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10 (2010), 479–489.
27. Cullen, T., Thomas, A.W., Webb, R., Phillips, T., Hughes, M.G., sIL-6R Is related to weekly training mileage and psychological well-being in athletes. Med. Sci. Sports Exerc. 49 (2017), 1176–1183.
28. Danese, A., McEwen, B.S., Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol. Behav. 106 (2012), 29–39.
29. Del Giudice, M., Ellis, B.J., Shirtcliff, E.A., The adaptive calibration model of stress responsivity. Neurosci. Biobehav. Rev. 35 (2011), 1562–1592.
30. Del Giudice, M., Gangestad, S.W., Kaplan, H.S., Life History Theory and Evolutionary Psychology. Buss, D.M., (eds.) The Handbook of Evolutionary Psychology – Vol 1: Foundations (2nd ed.), 2015, Wiley, New York, 88–114.
31. DeRijk, R., Michelson, D., Karp, B., Petrides, J., Galliven, E., Deuster, P., Sternberg, E.M., Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNFα) production in humans: high sensitivity of TNFα and resistance of IL-6. J. Clin. Endocrinol. Metabol. 82:7 (1997), 2182–2191.
32. Dhabhar, F.S., Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 16 (2009), 300–317.
33. Dinarello, C.A., Immunological and inflammatory functions of the interleukin-1 family. Annual review of immunology 27 (2009), 519–550.
34. Di Napoli, M., Godoy, D.A., Campi, V., Masotti, L., Smith, C.J., Jones, A.R.P., Pirici, D., C-reactive protein in intracerebral hemorrhage: time course, tissue localization, and prognosis. Neurology 79 (2012), 690–699.
35. Dou, H., Romero-Lucas, M., Bagi, Z., Caveolin-1 is a negative regulator of ADAM17 in adipose tissue vascular endothelium. FASEB J. 29:1 Supplement (2015), 634–639.
36. Dou, H., Feher, A., Davila, A.C., Romero, M.J., Patel, V.S., Kamath, V.M., Weintraub, N.L., Role of adipose tissue endothelial ADAM17 in age-related coronary microvascular dysfunctionhighlights. Arterioscler. Thromb. Vasc. Biol. 37:6 (2017), 1180–1193.
37. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctôt, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67 (2010), 446–457.
38. Du Clos, T.W., Mold, C., C-reactive protein. Immunol. Res. 30 (2004), 261–277.
39. Du Preez, A., Leveson, J., Zunszain, P.A., Pariante, C.M., Inflammatory insults and mental health consequences: does timing matter when it comes to depression?. Psychol. Med. 46 (2016), 2041–2057.
40. Ehrlich, K.B., Miller, G.E., Rohleder, N., Adam, E.K., Trajectories of relationship stress and inflammatory processes in adolescence. Dev. Psychopathol. 28 (2016), 127–138.
41. Eisenhardt, S.U., Thiele, J.R., Bannasch, H., Stark, G.B., Peter, K., C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 8 (2009), 3885–3892.
42. Elliot, A.J., Chapman, B.P., Socioeconomic status, psychological resources, and inflammatory markers: results from the MIDUS study. Health Psychol. 35 (2016), 1205–1213.
43. Elliot, A.J., Turiano, N.A., Chapman, B.P., Socioeconomic status interacts with conscientiousness and neuroticism to predict circulating concentrations of inflammatory markers. Ann. Behav. Med. 51 (2017), 240–250.
44. Ellis, B.J., Del Giudice, M., Shirtcliff, E.A., The Adaptive Calibration Model of Stress Responsivity: Concepts, Findings, and Implications for Developmental Psychopathology. Beauchaine, T.P., Hinshaw, S.P., (eds.) Child and Adolescent Psychopathology, 3rd ed., 2017, Wiley, New York, 237–276.
45. Fagundes, C.P., Way, B., Early-life stress and adult inflammation. Curr. Directions Psychol. Sci. 23 (2014), 277–283.
46. Fantuzzi, G., Faggioni, R., Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68 (2000), 437–446.
47. Fernandes, B.S., Steiner, J., Bernstein, H.G., Dodd, S., Pasco, J.A., Dean, O.M., Berk, M., C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol. Psychiatry 21 (2016), 554–564.
48. Fiorentino, L., Vivanti, A., Cavalera, M., Marzano, V., Ronci, M., Fabrizi, M., Lauro, R., Increased tumor necrosis factor α–converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 51:1 (2010), 103–110.
49. Friedman, E.M., Herd, P., Income, education, and inflammation: differential associations in a national probability sample (the MIDUS study). Psychosom. Med. 72 (2010), 290–300.
50. Fuster, J.J., Walsh, K., The good, the bad, and the ugly of interleukin-6 signaling. EMBO J. 33 (2014), 1425–1427.
51. Gabay, C., Gigley, J., Sipe, J., Arend, W.P., Fantuzzi, G., Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo. Eur. J. Immunol. 31 (2001), 490–499.
52. Garbers, C., Hermanns, H.M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., Scheller, J., Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev. 23 (2012), 85–97.
53. Georgiev, A.V., Kuzawa, C.W., McDade, T.W., Early developmental exposures shape trade-offs between acquired and innate immunity in humans. Evol. Med. Public Health 2016 (2016), 256–269.
54. Gold, P.W., Chrousos, G.P., Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7 (2002), 254–275.
55. Goldberg, E.L., Dixit, V.D., Drivers of age-related inflammation and strategies for healthspan extension. Immunol. Rev. 265 (2015), 63–74.
56. Gunnar, M., Quevedo, K., The neurobiology of stress and development. Annu. Rev. Psychol. 58 (2007), 145–173.
57. Haapakoski, R., Mathieu, J., Ebmeier, K.P., Alenius, H., Kivimäki, M., Cumulative meta-analysis of interleukins 6 and 1β tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav. Immun. 49 (2015), 206–215.
58. Haddick, P.C., Larson, J.L., Rathore, N., Bhangale, T.R., Phung, Q.T., Srinivasan, K., Farrer, L.A., A Common variant of IL-6R is associated with elevated IL-6 pathway activity in alzheimer's disease brains. J. Alzheimers Dis. 56:3 (2017), 1037–1054.
59. Himmerich, H., Fulda, S., Linseisen, J., Seiler, H., Wolfram, G., Himmerich, S., Pollmächer, T., TNF-α soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur. Cytokine Netw. 17:3 (2006), 196–201.
60. Horowitz, M.A., Zunszain, P.A., Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin. Ann. N. Y. Acad. Sci. 1351 (2015), 68–79.
61. Hosokawa, Y., Shindo, S., Hosokawa, I., Ozaki, K., Matsuo, T., IL-6 trans-signaling enhances CCL20 production from IL-1β-stimulated human periodontal ligament cells. Inflammation 37:2 (2014), 381–386.
62. Houston, A.I., McNamara, J.M., Barta, Z., Klasing, K.C., The effect of energy reserves and food availability on optimal immune defence. Proc. R. Soc. London B 274 (2007), 2835–2842.
63. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71 (2009), 171–186.
64. Ispirlidis, I., Fatouros, I.G., Jamurtas, A.Z., Nikolaidis, M.G., Michailidis, I., Douroudos, I., Alexiou, V., Time-course of changes in inflammatory and performance responses following a soccer game. Clin. J. Sport Med. 18 (2008), 423–431.
65. Janicki-Deverts, D., Cohen, S., Matthews, K.A., Gross, M.D., Jacobs, D.R. Jr, Socioeconomic status, antioxidant micronutrients, and correlates of oxidative damage: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosomatic Med., 71(5), 2009, 541.
66. Juster, R.P., McEwen, B.S., Sleep and chronic stress: new directions for allostatic load research. Sleep Med. 16 (2015), 7–8.
67. Kasapis, C., Thompson, P.D., The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J. Am. Coll. Cardiol. 45 (2005), 1563–1569.
68. Kinney, D.K., Tanaka, M., An evolutionary hypothesis of depression and its symptoms, adaptive value, and risk factors. J. Nerv. Mental Dis. 197 (2009), 561–567.
69. Köhler, C.A., Freitas, T.H., Maes, M., Andrade, N.Q., Liu, C.S., Fernandes, B.S., Raison, C.L., Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr. Scand. 135 (2017), 373–387.
70. Koopman, J.J., van Bodegom, D., Jukema, J.W., Westendorp, R.G., Risk of cardiovascular disease in a traditional African population with a high infectious load: a population-based study. PLoS One, 7, 2012, e46855.
71. Koster, A., Bosma, H., Penninx, B.W., Newman, A.B., Harris, T.B., van Eijk, J.T.M., Ayonayon, H.N., Association of inflammatory markers with socioeconomic status. J. Gerontol. A 61 (2006), 284–290.
72. Krogh-Madsen, R., Plomgaard, P., Møller, K., Mittendorfer, B., Pedersen, B.K., Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am. J. Physiol. Endocrinol. Metab. 291 (2006), E108–E114.
73. Kuhlman, K.R., Chiang, J.J., Horn, S., Bower, J.E., Developmental psychoneuroendocrine and psychoneuroimmune pathways from childhood adversity to disease. Neurosci. Biobehav. Rev. 80 (2017), 166–184.
74. Kunz-Ebrecht, S.R., Mohamed-Ali, V., Feldman, P.J., Kirschbaum, C., Steptoe, A., Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav. Immun. 17 (2003), 373–383.
75. Lamers, F., Beekman, A.T.F., Van Hemert, A.M., Schoevers, R.A., Penninx, B.W.J.H., Six-year longitudinal course and outcomes of subtypes of depression. Br. J. Psychiatry 208 (2016), 62–68.
76. Lamers, F., Vogelzangs, N., Merikangas, K.R., De Jonge, P., Beekman, A.T.F., Penninx, B.W.J.H., Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 18 (2013), 692–699.
77. Li, Y., Zhong, X., Cheng, G., Zhao, C., Zhang, L., Hong, Y., Wang, Z., Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis 259 (2017), 75–82.
78. Liu, R.S., Aiello, A.E., Mensah, F.K., Gasser, C.E., Rueb, K., Cordell, B., Burgner, D.P., Socioeconomic status in childhood and C reactive protein in adulthood: a systematic review and meta-analysis. J. Epidemiol. Community Health 71 (2017), 817–826.
79. Lo, C.W., Chen, M.W., Hsiao, M., Wang, S., Chen, C.A., Hsiao, S.M., Wei, L.H., IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res. 71:2 (2011), 424–434.
80. Lochmiller, R.L., Deerenberg, C., Trade-offs in evolutionary immunology: just what is the cost of immunity?. Oikos 88 (2000), 87–98.
81. Luchetti, M., Barkley, J.M., Stephan, Y., Terracciano, A., Sutin, A.R., Five-factor model personality traits and inflammatory markers: new data and a meta-analysis. Psychoneuroendocrinology 50 (2014), 181–193.
82. Marott, S.C., Nordestgaard, B.G., Zacho, J., Friberg, J., Jensen, G.B., Tybjærg-Hansen, A., Benn, M., Does elevated C-reactive protein increase atrial fibrillation risk? a mendelian randomization of 47,000 individuals from the general population. J. Am. Coll. Cardiol. 56 (2010), 789–795.
83. Marsland, A.L., Walsh, C., Lockwood, K., John-Henderson, N.A., The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis. Brain Behav. Immun., 2017.
84. Martinon, F., Mayor, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009), 229–265.
85. Matsui, Y., Tomaru, U., Miyoshi, A., Ito, T., Fukaya, S., Miyoshi, H., Ishizu, A., Overexpression of TNF-α converting enzyme promotes adipose tissue inflammation and fibrosis induced by high fat diet. Exp. Mol. Pathol. 97:3 (2014), 354–358.
86. Mauer, J., Denson, J.L., Brüning, J.C., Versatile functions for IL-6 in metabolism and cancer. Trends Immunol. 36 (2015), 92–101.
87. Mavilio, M., Marchetti, V., Fabrizi, M., Stöhr, R., Marino, A., Casagrande, V., Garret, C., A role for Timp3 in microbiota-driven hepatic steatosis and metabolic dysfunction. Cell Rep. 16:3 (2016), 731–743.
88. McDade, T.W., Life history theory and the immune system: steps toward a human ecological immunology. Am. J. Phys. Anthropol. 122 (2003), 100–125.
89. McDade, T.W., Early environments and the ecology of inflammation. Proc. Nat. Acad. Sci. U.S.A. 109 (2012), 17281–17288.
90. McDade, T.W., Borja, J.B., Largado, F., Adair, L.S., Kuzawa, C.W., Adiposity and chronic inflammation in young women predict inflammation during normal pregnancy in the Philippines. J. Nutr. 146 (2016), 353–357.
91. McDade, T.W., Georgiev, A.V., Kuzawa, C.W., Trade-offs between acquired and innate immune defenses in humans. Evol. Med. Public Health 2016 (2016), 1–16.
92. McDade, T.W., Hoke, M., Borja, J.B., Adair, L.S., Kuzawa, C., Do environments in infancy moderate the association between stress and inflammation in adulthood? Initial evidence from a birth cohort in the Philippines. Brain Behav. Immun. 31 (2013), 23–30.
93. Mcdade, T.W., Tallman, P.S., Madimenos, F.C., Liebert, M.A., Cepon, T.J., Sugiyama, L.S., Snodgrass, J.J., Analysis of variability of high sensitivity C-reactive protein in lowland Ecuador reveals no evidence of chronic low-grade inflammation. Am. J. Hum. Biol. 24 (2012), 675–681.
94. McEwen, B.S., Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87 (2007), 873–904.
95. McEwen, B.S., Brain on stress: how the social environment gets under the skin. Proc. Nat. Acad. Sci. U.S.A. 109 (2012), 17180–17185.
96. McFarlin, B.K., Johnston, C.A., Tyler, C., Hutchison, A.T., Kueht, M.L., Reeves, R., Foreyt, J.P., Inflammatory markers are elevated in overweight Mexican-American children. Pediatric Obesity 2:4 (2007), 235–241.
97. Medzhitov, R., Schneider, D.S., Soares, M.P., Disease tolerance as a defense strategy. Science 335 (2012), 936–941.
98. Mihlan, M., Blom, A.M., Kupreishvili, K., Lauer, N., Stelzner, K., Bergström, F., Zipfel, P.F., Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J. 25 (2011), 4198–4210.
99. Millar, K., Lloyd, S.M., McLean, J.S., Batty, G.D., Burns, H., Cavanagh, J., Mõttus, R., Personality, socio-economic status and inflammation: cross-sectional, population-based study. PLoS One, 8, 2013, e58256.
100. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16 (2016), 22–34.
101. Miller, G., Chen, E., Cole, S.W., Health psychology: developing biologically plausible models linking the social world and physical health. Annu. Rev. Psychol. 60 (2009), 501–524.
102. Miller, G.E., Chen, E., Parker, K.J., Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol. Bull. 137 (2011), 959–997.
103. Miller, G.E., Chen, E., Sze, J., Marin, T., Arevalo, J.M., Doll, R., Cole, S.W., A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-κB signaling. Biol. Psychiatry 64:4 (2008), 266–272.
104. Miller, M.R., White, A., Boots, M., Host life span and the evolution of resistance characteristics. Evolution 61 (2007), 2–14.
105. Minihane, A.M., Vinoy, S., Russell, W.R., Baka, A., Roche, H.M., Tuohy, K.M., McArdle, H.J., Low-grade inflammation, diet composition and health: current research evidence and its translation. Br. J. Nutr. 114 (2015), 999–1012.
106. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., Coppack, S.W., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α in vivo. J. Clin. Endocrinol. Metab. 82 (1997), 4196–4200.
107. Muñoz-Durango, N., Vecchiola, A., Gonzalez-Gomez, L.M., Simon, F., Riedel, C.A., Fardella, C.E., Kalergis, A.M., Modulation of immunity and inflammation by the mineralocorticoid receptor and aldosterone. Biomed. Res. Int., 2015.
108. Nieman, D.C., Davis, J.M., Henson, D.A., Walberg-Rankin, J., Shute, M., Dumke, C.L., Lee, W.J., Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J. Appl. Physiol. 94:5 (2003), 1917–1925.
109. Nitsch, D., Molokhia, M., Smeeth, L., DeStavola, B.L., Whittaker, J.C., Leon, D.A., Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am. J. Epidemiol. 163 (2006), 397–403.
110. Nguyen-Vermillion, A., Juul, S.E., McPherson, R.J., Ledbetter, D.J., Time course of C-reactive protein and inflammatory mediators after neonatal surgery. J. Pediatr. 159 (2011), 121–126.
111. Osler, M., Bendix, L., Rask, L., Rod, N.H., Stressful life events and leucocyte telomere length: do lifestyle factors, somatic and mental health, or low grade inflammation mediate this relationship? Results from a cohort of Danish men born in 1953. Brain Behav. Immun. 58 (2016), 248–253.
112. Pagano, S., Keller, P.F., Vuilleumier, N., CRP Pro-inflammatory signalling in atherosclerosis: myth or reality?. Curr. Signal Transduct. Ther. 7 (2012), 142–148.
113. Parkin, J., Cohen, B., An overview of the immune system. Lancet 357 (2001), 1777–1789.
114. Pedersen, B.K., Febbraio, M.A., Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8 (2012), 457–465.
115. Petersen, A., Pedersen, B., The role of IL-6 in mediating the anti-inflammatory effects of exercise. J. Physiol. Pharmacol. 57 (2006), 43–51.
116. Prins, B.P., Abbasi, A., Wong, A., Vaez, A., Nolte, I., Franceschini, N., Valdes, A.M., Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium Mendelian randomization study. PLoS Med., 13, 2016, e1001976.
117. Råberg, L., Graham, A.L., Read, A.F., Decomposing health: tolerance and resistance to parasites in animals. Philos. Trans. R. Soc. London B 364 (2009), 37–49.
118. Raichlen, D.A., Pontzer, H., Harris, J.A., Mabulla, A.Z., Marlowe, F.W., Josh Snodgrass, J., Wood, B.M., Physical activity patterns and biomarkers of cardiovascular disease risk in hunter-gatherers. Am. J. Hum. Biol., 29, 2017, e22919.
119. Raison, C.L., Miller, A.H., The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol. Psychiatry 18 (2013), 15–37.
120. Raison, C.L., Miller, A.H., Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias. Brain Behav. Immun. 31 (2013), 1–8.
121. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Miller, A.H., A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70 (2013), 31–41.
122. Rauw, W.M., Immune response from a resource allocation perspective. Front. Genet., 3, 2012, 267.
123. Rethorst, C.D., Greer, T.L., Toups, M.S.P., Bernstein, I., Carmody, T.J., Trivedi, M.H., IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder. Transl. Psychiatry, 5, 2015, e611.
124. Roff, D.A., Life History Evolution. 2002, Sinauer, Sunderland, MA.
125. Rose-John, S., Winthrop, K., Calabrese, L., The role of IL-6 in host defense against infections: immunobiology and clinical implications. Nat. Rev. Rheumatol. 13 (2017), 399–409.
126. Ruiz-Núñez, B., Pruimboom, L., Dijck-Brouwer, D.J., Muskiet, F.A., Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context. J. Nutr. Biochem. 24 (2013), 1183–1201.
127. Samols, D., Agrawal, A., Kushner, I., Acute phase proteins. eLS, 2001, 10.1038/npg.els.0000497.
128. Schaller, M., The Behavioral Immune System. Buss, D.M., (eds.) The Handbook of Evolutionary Psychology, 2nd ed., 2015, Wiley, Hoboken, NJ, 206–224.
129. Schaper, F., Rose-John, S., Interleukin-6: biology, signaling and strategies of blockade. Cytokine Growth Factor Rev. 26 (2015), 475–487.
130. Scheller, J., Chalaris, A., Schmidt-Arras, D., Rose-John, S., The pro-and anti-inflammatory properties of the cytokine interleukin-6. BBA 1813 (2011), 878–888.
131. Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S.C., Dinarello, C.A., Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75 (1990), 40–47.
132. Schmit, X., Vincent, J.L., The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 36 (2008), 213–219.
133. Schnabel, R.B., Yin, X., Larson, M.G., Yamamoto, J.F., Fontes, J.D., Kathiresan, S., Murabito, J.M., Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the communitysignificance. Arteriosclerosis Thrombosis Vasc. Biol. 33:7 (2013), 1728–1733.
134. Sears, B.F., Rohr, J.R., Allen, J.E., Martin, L.B., The economy of inflammation: when is less more?. Trends Parasitol. 27 (2011), 382–387.
135. Segerstrom, S.C., Miller, G.E., Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull., 130, 2004, 601.
136. Seppälä J., Vanhala, M., Kautiainen, H., Eriksson, J., Kampman, O., Mäntyselkä P., Koponen, H., Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study. J. Affective Disord. 136 (2012), 543–549.
137. Silverman, M.N., Miller, A.H., Biron, C.A., Pearce, B.D., Characterization of an interleukin-6-and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. Endocrinology 145:8 (2004), 3580–3589.
138. Singh-Manoux, A., Shipley, M.J., Bell, J.A., Canonico, M., Elbaz, A., Kivimäki, M., Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality. CMAJ : Can. Med. Assoc. J. 189:10 (2017), E384–E390.
139. Sommer, I., Griebler, U., Mahlknecht, P., Thaler, K., Bouskill, K., Gartlehner, G., Mendis, S., Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health, 15, 2015, 914.
140. Sowa-Kućma, M., Styczeń K., Siwek, M., Misztak, P., Nowak, R.J., Dudek, D., Maes, M., Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 81 (2018), 372–383.
141. Steensberg, A., Febbraio, M.A., Osada, T., Schjerling, P., Hall, G., Saltin, B., Pedersen, B.K., Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J. Physiol. 537:2 (2001), 633–639.
142. Steptoe, A., Hamer, M., Chida, Y., The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 21 (2007), 901–912.
143. Stieglitz, J., Trumble, B.C., Thompson, M.E., Blackwell, A.D., Kaplan, H., Gurven, M., Depression as sickness behavior? A test of the host defense hypothesis in a high pathogen population. Brain Behav. Immun. 49 (2015), 130–139.
144. Straub, R.H., Cutolo, M., Buttgereit, F., Pongratz, G., Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases. J. Intern. Med. 267 (2010), 543–560.
145. Stringhini, S., Batty, G.D., Bovet, P., Shipley, M.J., Marmot, M.G., Kumari, M., Kivimäki, M., Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk: the Whitehall II prospective cohort study. PLoS Med., 10, 2013, e1001479.
146. Stringhini, S., Carmeli, C., Jokela, M., Avendaño, M., Muennig, P., Guida, F., Chadeau-Hyam, M., Socioeconomic status and the 25× 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women. Lancet 389 (2017), 1229–1237.
147. Sturgeon, J.A., Arewasikporn, A., Okun, M.A., Davis, M.C., Ong, A.D., Zautra, A.J., The psychosocial context of financial stress: implications for inflammation and psychological health. Psychosom. Med., 78, 2016, 134.
148. Szabo-Fresnais, N., Lefebvre, F., Germain, A., Fischmeister, R., Pomérance, M., A new regulation of IL-6 production in adult cardiomyocytes by β-adrenergic and IL-1β receptors and induction of cellular hypertrophy by IL-6 trans-signalling. Cell. Signal. 22:7 (2010), 1143–1152.
149. Taylor, M.A., Fink, M., Restoring melancholia in the classification of mood disorders. J. Affective Disord. 105 (2008), 1–14.
150. Thiele, J.R., Habersberger, J., Braig, D., Schmidt, Y., Goerendt, K., Maurer, V., Kolodgie, F., The dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: In vivo proof of a powerful pro-inflammatory mechanism and a new anti-inflammatory strategy. Circulation 130 (2014), 35–50.
151. Timper, K., Denson, J.L., Steculorum, S.M., Heilinger, C., Engström-Ruud, L., Wunderlich, C.M., Brüning, J.C., IL-6 improves energy and glucose homeostasis in obesity via enhanced central IL-6 trans-signaling. Cell Rep. 19 (2017), 267–280.
152. Trial, J., Potempa, L.A., Entman, M.L., The role of C-reactive protein in innate and acquired inflammation: new perspectives. Inflammation Cell Signaling, 3, 2016, e1409.
153. VanderWeele, T.J., Tchetgen, E.J.T., Cornelis, M., Kraft, P., Methodological challenges in Mendelian randomization. Epidemiology 25 (2014), 427–435.
154. van Dongen, J., Willemsen, G., Heijmans, B.T., Neuteboom, J., Kluft, C., Jansen, R., Boomsma, D.I., Longitudinal weight differences, gene expression and blood biomarkers in BMI-discordant identical twins. Int. J. Obesity 39:6 (2015), 899–909.
155. Velásquez, I.M., Golabkesh, Z., Källberg, H., Leander, K., de Faire, U., Gigante, B., Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction. Atherosclerosis 240:2 (2015), 477–481.
156. Waage, A., Slupphaug, G., Shalaby, R., Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblasts. Eur. J. Immunol. 20 (1990), 2439–2443.
157. Wium-Andersen, M.K., Ørsted, D.D., Nordestgaard, B.G., Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: a mendelian randomization study. Biol. Psychiatry 76 (2014), 249–257.
158. Wong, B.C.F., Chau, C.K.L., Ao, F.K., Mo, C.H., Wong, S.Y., Wong, Y.H., So, H.C., Differential associations of various depression-related phenotypes with cardiometabolic risks: identification of shared genetic factors and implications for drug repositioning. BioRxiv, 2017, 10.1101/140590.
159. Xu, P.C., Lin, S., Yang, X.W., Gu, D.M., Yan, T.K., Wei, L., Wang, B.L., C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis. BMC Immunol., 16, 2015, 10.
160. Yeager, M.P., Pioli, P.A., Guyre, P.M., Cortisol exerts bi-phasic regulation of inflammation in humans. Dose-response 9 (2011), 332–347.
161. Žarkovic, M., Ignjatovic, S., Dajak, M., Ciric, J., Beleslin, B., Savic, S., Trbojevic, B., Cortisol response to ACTH stimulation correlates with blood interleukin 6 concentration in healthy humans. Eur. J. Endocrinol. 159:5 (2008), 649–652.
162. Zhang, F., Chen, Y., Heiman, M., Dimarchi, R., Leptin: structure, function and biology. Vitam. Horm. 71 (2005), 345–372.